These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1943122)

  • 21. Significant effects of Z-Gln-Val-Val-OME, common sequences of thiol proteinase inhibitors on thiol proteinases.
    Teno N; Tsuboi S; Itoh N; Okamoto H; Okada Y
    Biochem Biophys Res Commun; 1987 Mar; 143(2):749-52. PubMed ID: 3566746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that serpin architecture intrinsically supports papain-like cysteine protease inhibition: engineering alpha(1)-antitrypsin to inhibit cathepsin proteases.
    Irving JA; Pike RN; Dai W; Brömme D; Worrall DM; Silverman GA; Coetzer TH; Dennison C; Bottomley SP; Whisstock JC
    Biochemistry; 2002 Apr; 41(15):4998-5004. PubMed ID: 11939796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trypanosomatid cysteine protease activity may be enhanced by a kininogen-like moiety from host serum.
    Lonsdale-Eccles JD; Mpimbaza GW; Nkhungulu ZR; Olobo J; Smith L; Tosomba OM; Grab DJ
    Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):549-56. PubMed ID: 7832773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kininogen in tumor-bearing mice.
    Okamoto H; Itoh N; Uwani M; Yokota S; Hatta A
    Adv Exp Med Biol; 1989; 247A():159-68. PubMed ID: 2603788
    [No Abstract]   [Full Text] [Related]  

  • 25. Diversity of rat brain cysteine proteinase inhibitors: isolation of low-molecular-weight cystatins and a higher-molecular weight T-kininogen-like glycoprotein.
    Marks N; Stern F; Chi LM; Berg MJ
    Arch Biochem Biophys; 1988 Dec; 267(2):448-58. PubMed ID: 3265047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of guinea-pig high-molecular-weight kininogen as multi-functional molecule.
    Yamamoto T
    Biochim Biophys Acta; 1987 Aug; 914(3):259-74. PubMed ID: 3113483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-kininogen inhibits kinin-mediated activation of ERK in endothelial cells.
    Leiva-Salcedo E; Perez V; Acuña-Castillo C; Walter R; Sierra F
    Biol Res; 2002; 35(2):287-94. PubMed ID: 12415746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Porcine high molecular weight kininogen: its purification and properties as a thiol proteinase inhibitor as compared to human high molecular weight kininogen.
    Tani Y; Ohkubo I; Higashiyama S; Kunimatsu M; Sasaki M
    Comp Biochem Physiol B; 1987; 88(2):429-41. PubMed ID: 3123124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Properties of chemically oxidized kininogens.
    Nieziołek M; Kot M; Pyka K; Mak P; Kozik A
    Acta Biochim Pol; 2003; 50(3):753-63. PubMed ID: 14515155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human high molecular weight kininogen as a thiol proteinase inhibitor: presence of the entire inhibition capacity in the native form of heavy chain.
    Higashiyama S; Ohkubo I; Ishiguro H; Kunimatsu M; Sawaki K; Sasaki M
    Biochemistry; 1986 Apr; 25(7):1669-75. PubMed ID: 3635411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and evaluation of chloromethyl sulfoxides as a new class of selective irreversible cysteine protease inhibitors.
    Brouwer AJ; Bunschoten A; Liskamp RM
    Bioorg Med Chem; 2007 Nov; 15(22):6985-93. PubMed ID: 17869119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping of functional domains of human high molecular weight and low molecular weight kininogens using murine monoclonal antibodies.
    Ishiguro H; Higashiyama S; Ohkubo I; Sasaki M
    Biochemistry; 1987 Nov; 26(22):7021-9. PubMed ID: 2447941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cysteine protease inhibition by azapeptide esters.
    Magrath J; Abeles RH
    J Med Chem; 1992 Nov; 35(23):4279-83. PubMed ID: 1447732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of inhibition of platelet calpain II by human kininogens.
    Bradford HN; Schmaier AH; Colman RW
    Biochem J; 1990 Aug; 270(1):83-90. PubMed ID: 2396995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cys25-nitrosylation inactivates papain.
    Venturini G; Fioravanti E; Colasanti M; Persichini T; Ascenzi P
    Biochem Mol Biol Int; 1998 Oct; 46(2):425-8. PubMed ID: 9801811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and characterization of acute phase rat plasma thiostatin.
    Rusiniak ME; Wagh PV; Bedi GS; Back N
    Prep Biochem; 1994 Feb; 24(1):41-59. PubMed ID: 7514789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mRNA for kininogens and thiostatins (major acute phase alpha 1-proteins) in the liver of kininogen-deficient rats.
    Fung WP; Milland J; Schreiber G
    Thromb Res; 1988 Apr; 50(1):113-20. PubMed ID: 3261051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The novel serpin endopin 2 demonstrates cross-class inhibition of papain and elastase: localization of endopin 2 to regulated secretory vesicles of neuroendocrine chromaffin cells.
    Hwang SR; Steineckert B; Toneff T; Bundey R; Logvinova AV; Goldsmith P; Hook VY
    Biochemistry; 2002 Aug; 41(33):10397-405. PubMed ID: 12173926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assay methods for prekallikrein and kininogens and their applications.
    Uchida Y; Ohishi S; Tanaka K; Harada Y; Ueno A; Katori M; Funahashi S; Hashimoto T; Ueno T; Kodama J
    Adv Exp Med Biol; 1979; 120A():173-84. PubMed ID: 495307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cathepsin L, but not cathepsin B, is a potential kininogenase.
    Desmazes C; Gauthier F; Lalmanach G
    Biol Chem; 2001 May; 382(5):811-5. PubMed ID: 11517935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.